Innovative Eye-D technology treats glaucoma through a sub-conjunctival implant that provides sustained release of medication, eliminating the daily use of eye drops. The implant simplifies the treatment process for patients, particularly the elderly, while addressing low persistence rates with traditional glaucoma therapies.